Literature DB >> 16714137

Resistance to fluoroquinolones in Salmonella: emerging mechanisms and resistance prevention strategies.

Etienne Giraud1, Sylvie Baucheron, Axel Cloeckaert.   

Abstract

We review the current state of knowledge about the genetic and biochemical mechanisms that mediate quinolone resistance in Salmonella. They include modifications of topoisomerase targets, increased efflux activity and the recently described topoisomerase protection by the plasmid-encoded Qnr protein. We discuss what factors may determine the order of implementation of these various mechanisms in a particular strain, and what strategies could be used to combat resistance, from the inhibition of mutagenesis mechanisms to counteracting, during fluoroquinolone treatment, of resistance mechanisms already set in the infecting strain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714137     DOI: 10.1016/j.micinf.2005.12.025

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  28 in total

1.  Occurrence of Antimicrobial-Resistant Escherichia coli and Salmonella enterica in the Beef Cattle Production and Processing Continuum.

Authors:  John W Schmidt; Getahun E Agga; Joseph M Bosilevac; Dayna M Brichta-Harhay; Steven D Shackelford; Rong Wang; Tommy L Wheeler; Terrance M Arthur
Journal:  Appl Environ Microbiol       Date:  2014-11-14       Impact factor: 4.792

2.  Mutant prevention concentration (MPC) of ciprofloxacin against Salmonella enterica of epidemic and poultry origin.

Authors:  Rafaela Ferrari; Marciane Magnani; Roberta Barreiros Souza; Maria Cristina Bronharo Tognim; Tereza Cristina Rocha Moreira Oliveira
Journal:  Curr Microbiol       Date:  2010-09-25       Impact factor: 2.188

3.  Antibacterial activities of nemonoxacin against clinical isolates of Staphylococcus aureus: an in vitro comparison with three fluoroquinolones.

Authors:  Zhaoxia Li; Youning Liu; Rui Wang; Aimin Li
Journal:  World J Microbiol Biotechnol       Date:  2014-08-18       Impact factor: 3.312

4.  Targeting quinolone- and aminocoumarin-resistant bacteria with new gyramide analogs that inhibit DNA gyrase.

Authors:  Katherine A Hurley; Thiago M A Santos; Molly R Fensterwald; Madhusudan Rajendran; Jared T Moore; Edward I Balmond; Brice J Blahnik; Katherine C Faulkner; Marie H Foss; Victoria A Heinrich; Matthew G Lammers; Lucas C Moore; Gregory D Reynolds; Galen P Shearn-Nance; Brian A Stearns; Zi W Yao; Jared T Shaw; Douglas B Weibel
Journal:  Medchemcomm       Date:  2017-02-27       Impact factor: 3.597

Review 5.  Emergence, distribution, and molecular and phenotypic characteristics of Salmonella enterica serotype 4,5,12:i:-.

Authors:  Andrea I Moreno Switt; Yesim Soyer; Lorin D Warnick; Martin Wiedmann
Journal:  Foodborne Pathog Dis       Date:  2009-05       Impact factor: 3.171

6.  Molecular level understanding of resistance to nalidixic acid in Salmonella enteric serovar typhimurium associates with the S83F sequence type.

Authors:  B Preethi; K Ramanathan
Journal:  Eur Biophys J       Date:  2015-09-02       Impact factor: 1.733

7.  Quinolone resistance of Salmonella enterica serovar Virchow isolates from humans and poultry in Israel: evidence for clonal expansion.

Authors:  Hadas Solnik-Isaac; Miriam Weinberger; Mina Tabak; Alon Ben-David; Dina Shachar; Sima Yaron
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

8.  ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.

Authors:  Yousef M Abouzeed; Sylvie Baucheron; Axel Cloeckaert
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

9.  Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators.

Authors:  Edel O'Regan; Teresa Quinn; Jean-Marie Pagès; Matthew McCusker; Laura Piddock; Séamus Fanning
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

10.  Antiquorum sensing and antibiofilm potential of biosynthesized silver nanoparticles of Myristica fragrans seed extract against MDR Salmonella enterica serovar Typhi isolates from asymptomatic typhoid carriers and typhoid patients.

Authors:  Senthilkumar Balakrishnan; Kalibulla Syed Ibrahim; Senbagam Duraisamy; Ilakkia Sivaji; Selvam Kandasamy; Anbarasu Kumarasamy; Nachimuthu Senthil Kumar
Journal:  Environ Sci Pollut Res Int       Date:  2019-12-13       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.